A Model That Is Built to “Win”

EP: 1.No Successor to OCM Would Disappoint

EP: 2.CMMI Open to Feedback, but EOM Out of the Blue

EP: 3.Some Practices That Did Not Do OCM Are Applying

EP: 4.Seven Tumor Types: Pros and Cons

Now Viewing

EP: 5.A Model That Is Built to “Win”

EP: 6.Addressing Health Equity and Social Needs

EP: 7.Is Five Years Long Enough?

EP: 8.Changes to MEOS and Barriers to Entry

EP: 9.Small Practices and Dual Risk: Considerations and Approaches

EP: 10.Does Pooling Make Sense?

EP: 11.What Would You Change About the EOM?

Panelists discuss the financial fallout from the design of the Enhancing Oncology Model (EOM), which responds to the reports that found the Oncology Care Model succeeded in delivering better care but didn't save enough Medicare enough money in its early years, at least not in practices that were less proficient in operating the model. Kashyap Patel, MD, suggests other payment model programs that could work in tandem with the EOM.